Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Arch Bronconeumol. 2017 Mar;53(3):128-149.
doi: 10.1016/j.arbres.2017.02.001.
Epub 2017 Mar 6.
[Article in
English,
Spanish]
Authors
Claus F Vogelmeier
1
, Gerard J Criner
2
, Fernando J Martínez
3
, Antonio Anzueto
4
, Peter J Barnes
5
, Jean Bourbeau
6
, Bartolome R Celli
7
, Rongchang Chen
8
, Marc Decramer
9
, Leonardo M Fabbri
10
, Peter Frith
11
, David M G Halpin
12
, M Victorina López Varela
13
, Masaharu Nishimura
14
, Nicolás Roche
15
, Roberto Rodríguez-Roisin
16
, Don D Sin
17
, Dave Singh
18
, Robert Stockley
19
, Jørgen Vestbo
18
, Jadwiga A Wedzicha
20
, Alvar Agustí
21
Affiliations
- 1 Universidad de Marburg, Marburg, Alemania, Miembro del Centro Alemán para Investigación Pulmonar (DZL). Electronic address: claus.vogelmeier@med.uni-marburg.de.
- 2 Lewis Katz School of Medicine at Temple University, Filadelfia, Pensilvania, EE. UU.
- 3 New York-Presbyterian Hospital, Weil Cornell Medical Center, Nueva York, Nueva York, EE. UU.
- 4 University of Texas Health Science Center and South Texas Veterans Health Care System, San Antonio, Texas, EE. UU.
- 5 National Heart and Lung Institute, Imperial College, Londres, Reino Unido.
- 6 McGill University Health Centre, McGill University, Montreal, Canadá.
- 7 Brigham and Women's Hospital Boston, Massachusetts, EE. UU.
- 8 Laboratorio Central Estatal para Enfermedades Respiratorias, Instituto de Enfermedades Respiratorias de Guangzhou, Primer Hospital Afiliado de la Universidad de Medicina de Guangzhou, Guangzhou, República Popular de China.
- 9 Universidad de Lovaina, Lovaina, Bélgica.
- 10 Universidad de Módena y Reggio Emilia, Módena, Italia.
- 11 Flinders University Faculty of Medicine, Bedford Park, South Australia Australia.
- 12 Royal Devon & Exeter Hospital, Exeter, Reino Unido.
- 13 Universidad de la República Montevideo, Uruguay.
- 14 Facultad de Medicina de la Universidad de Hokkaido, Japón.
- 15 Hôpital Cochin (APHP), Universidad Paris Descartes, París, Francia.
- 16 Instituto del Tórax, Hospital Clínic, Universitat de Barcelona, Barcelona, España.
- 17 St. Paul's Hospital, University of British Columbia, Vancouver, Canadá.
- 18 University of Manchester, Manchester, Reino Unido.
- 19 University Hospital, Birmingham, Reino Unido.
- 20 Imperial College London, Londres, Reino Unido.
- 21 Hospital Clínic, Universitat de Barcelona, Ciberes, Barcelona, España.
Abstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of COPD has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed.
Keywords:
COPD; COPD management; COPD prevention; Chronic obstructive pulmonary disease; Diagnóstico de enfermedad pulmonar obstructiva crónica; EPOC; Evaluación; Prevención; diagnosis.
Copyright © 2017 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Humans
-
Practice Guidelines as Topic*
-
Pulmonary Disease, Chronic Obstructive / diagnosis*
-
Pulmonary Disease, Chronic Obstructive / prevention & control
-
Pulmonary Disease, Chronic Obstructive / therapy*